Table 1 Phenotypic characterization of ADSCs-SVF after isolation and activation with PRP and photobiostimulation in all patients enrolled (n=14) in the study
| Â | Differentiation markers | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Patients | CD29 | CD13 | CD73 | CD90 | CD105 | CD116 | CD44 | CD34 | CD31 | CD45 |
1 | 65.2 | 41.8 | 61.6 | 60.1 | 49.2 | 59.1 | 88.5 | 21.2 | 0.8 | 0.1 |
2 | 78.3 | 50.3 | 66.8 | 45.3 | 53.1 | 56.2 | 91.2 | 25.5 | 0.5 | 0.2 |
3 | 81.5 | 47.9 | 56.3 | 57.6 | 47.7 | 59.2 | 92.1 | 31.1 | 0.3 | 0 |
4 | 79.9 | 51.8 | 66.2 | 61.8 | 50.6 | 61.8 | 90.2 | 35.6 | 0 | 0.1 |
5 | 80.4 | 37.2 | 55.2 | 45.7 | 48.7 | 49.4 | 92.7 | 22.2 | 0.2 | 0.5 |
6 | 82.2 | 54.1 | 78.9 | 69.8 | 54.5 | 63.9 | 91.4 | 35.7 | 1 | 0 |
7 | 81.6 | 53.3 | 76.6 | 68.8 | 49.9 | 62.8 | 88.6 | 27.9 | 0.7 | 0 |
8 | 86.7 | 56.3 | 68.7 | 59.9 | 51.4 | 62.6 | 90.1 | 33.1 | 0.8 | 0.2 |
9 | 77.4 | 43.6 | 57.5 | 64.1 | 49.4 | 62.7 | 93.2 | 27.9 | 1.1 | 0.1 |
10 | 78.8 | 58.7 | 66.9 | 52.8 | 45.1 | 62.9 | 88.9 | 21.6 | 08 | 0.1 |
11 | 76.9 | 60.1 | 77.9 | 59.6 | 48.8 | 59.6 | 89.4 | 26.4 | 0.9 | 1 |
12 | 78.9 | 51.9 | 50.9 | 59.9 | 52.2 | 63.8 | 90.6 | 37.1 | 0.9 | 0.3 |
13 | 80.3 | 52.8 | 79.1 | 61.7 | 49.8 | 64.1 | 89.3 | 25.4 | 1 | 0.2 |
14 | 79.7 | 49.6 | 75.8 | 65.5 | 51.8 | 63.7 | 88.8 | 30.5 | 0.6 | 0 |
Median % (range) | 79.1 | 54.2 | 67.7 | 59.3 | 50.1 | 60.8 | 90,3 | 28.8 | 0.7 | 0.2 |
(65.2 – 86.7) | (37.2 – 67.1) | (55.2 – 79.1) | (45.3 – 69.4) | (48.7 – 58.2) | (49.4- 64.1) | (88.5 – 93.6) | (21.2 – 37.1) | (0–1.1) | (0.2-1) | |